Immunology and Ligand Assay
Search Results
-
CLSI DI03A
Agglutination Analyses: Antibody Characteristics, Methodology, Limitations, and Clinical Validation; Approved Guideline, DI03-A
standard by Clinical and Laboratory Standards Institute, 10/19/1993.
Languages:
-
CLSI I/LA20
Analytical Performance Characteristics, Quality Assurance, and Clinical Utility of Immunological Assays for Human Immunoglobulin E Antibodies of Defined Allergen Specificities, 3rd Edition, ILA20Ed3E
standard by Clinical and Laboratory Standards Institute, 10/01/2016.
Languages: English
Historical Editions: CLSI I/LA20-A2
-
CLSI C59-A [ Withdrawn ]
Apolipoprotein Immunoassays: Development and Recommended Performance Characteristics; Approved Guideline, C59AE
standard by Clinical and Laboratory Standards Institute, 09/19/1997.
Languages:
-
CLSI LA01A2
Assessing the Quality of Radioimmunoassay Systems; Approved Guideline, LA01-A2
standard by Clinical and Laboratory Standards Institute, 12/19/1994.
Languages: English
-
HISTORICAL
CLSI QMS15-A
This document has been replaced. View the most recent version.
Assessments: Laboratory Internal Audit Program; Approved Guideline, QMS15AE
standard by Clinical and Laboratory Standards Institute, 12/01/2013.
Languages: English
Historical Editions: CLSI QMS15
-
HISTORICAL
CLSI LA04-A5
This document has been replaced. View the most recent version.
Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard - Fifth Edition, LA4A5
standard by Clinical and Laboratory Standards Institute, 07/01/2007.
Languages:
Historical Editions: CLSI NBS01, CLSI NBS01-A6
-
HISTORICAL
CLSI NBS01-A6
This document has been replaced. View the most recent version.
Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard - Sixth Edition, NBS01A6E
standard by Clinical and Laboratory Standards Institute, 07/01/2013.
Languages: English
Historical Editions: CLSI NBS01, CLSI LA04-A5
-
CLSI I/LA21-A2
Clinical Evaluation of Immunoassays; Approved Guideline--Second Edition, ILA21A2E
standard by Clinical and Laboratory Standards Institute, 01/01/2008.
Languages: English
-
CLSI I/LA34-A
Design and Validation of Immunoassays for Assessment of Human Allergenicity of New Biotherapeutic Drugs; Approved Guideline, I/LA34AE
standard by Clinical and Laboratory Standards Institute, 06/01/2011.
Languages:
-
CLSI QMS12
Developing and Using Quality Indicators for Laboratory Improvement, 2nd Edition, QMS12Ed2E
standard by Clinical and Laboratory Standards Institute, 03/29/2019.
Languages: English
Historical Editions: CLSI QMS12-A, CLSI GP35-P
